Impact BioMedical (IBO) director Grady sold 50,000 shares for $32.5K at $0.65
Insider transactions reported
Jason Grady (director at Impact BioMedical Inc., IBO) reported that they sold 50,000 shares for $32.5K at $0.65 on Mar 23, 2026. After these transactions the filing shows 250,182 shares held directly.
- Reporting person
- Grady Jason
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Mar 23, 2026 | Open-market sale (S) | Common Stock | -50,000 | $0.65 | $32.5K | 250,182 direct |
Holdings before and after
- Common Stock: 300,182 to 250,182 direct
Transaction codes in this filing
- Open-market sale:
- Code S marks a sale in the open market or a private deal. The insider received cash for these securities.
FAQ
What did Grady report in this IBO Form 4?
Jason Grady (director at Impact BioMedical Inc., IBO) reported that they sold 50,000 shares for $32.5K at $0.65 on Mar 23, 2026. After these transactions the filing shows 250,182 shares held directly.
How many IBO shares does Grady hold after this filing?
The filing shows 250,182 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
Was this IBO insider sale made under a 10b5-1 plan?
The filing's footnotes do not mention a Rule 10b5-1 trading plan.
What does transaction code S mean on an SEC Form 4?
Code S marks a sale in the open market or a private deal. The insider received cash for these securities.
Historical context for IBO
Earlier insider filings at IBO
- Jan 6, 2026Large owner Dss, Inc. sold $88,006 worth of shares (161,000 units at $0.55), decreasing direct ownership by 23% to 545,024 units (SEC Form 4)
- Apr 8, 2025Large owner Dss, Inc. sold $845,013 worth of shares (890,800 units at $0.95), decreasing direct ownership by 85% to 161,100 units (SEC Form 4)
- Apr 7, 2025Director Chan Heng Fai Ambrose sold $174,020 worth of shares (351,555 units at $0.49) (SEC Form 4)
- Apr 4, 2025Director Chan Heng Fai Ambrose sold $1,122,920 worth of shares (1,689,693 units at $0.66) (SEC Form 4)
- Apr 3, 2025Director Chan Heng Fai Ambrose sold $392,800 worth of shares (400,000 units at $0.98) and sold $2,520,021 worth of shares (2,126,918 units at $1.18) (SEC Form 4)
Keep researching IBO
- IBO insider tradesEvery buy and sale reported by Impact BioMedical Inc. officers, directors and large holders.
- What is Form 4?The SEC filing that reports a change in an insider's holdings, such as a purchase, sale, option exercise or grant, generally within two business days.
- Form 4 explainedForm 4 is the SEC filing that discloses when officers, directors and 10% owners buy or sell company stock, due within 2 business days. Learn every key field and code.
- Insider trading trackerThe latest insider buys and sales across every stock.
- IBO financial statementsRevenue, profit, cash flow and balance sheet from Impact BioMedical Inc.'s SEC filings.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2024
Follow IBO and get a push notification the moment its next story breaks.